Results 131 to 140 of about 1,109,966 (258)

Pain Assessment in Oral Medicine through Its Different Dimensions: A Comprehensive Review. [PDF]

open access: yesDent J (Basel), 2023
Scribante A   +5 more
europepmc   +1 more source

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son   +3 more
wiley   +1 more source

How Oral Medicine Practice Is Reported: A Scoping Review of 114,971 Patients. [PDF]

open access: yesOral Dis
Barcellos Calderipe C   +6 more
europepmc   +1 more source

Assessing Tele-Oral Medicine in Saudi Arabia: A Cross-Sectional Study on Specialists' Experiences and Effectiveness in Oral Healthcare. [PDF]

open access: yesHealthcare (Basel), 2023
Akeel S   +9 more
europepmc   +1 more source

Shedding light on Brazil's contribution to photobiomodulation research in oral medicine: a bibliometric study. [PDF]

open access: yesBraz Oral Res
Schuch LF   +11 more
europepmc   +1 more source

Marked Long‐Term Improvement in Lung Function in Melanoma Differentiation–Associated Protein 5 Antibody–Positive Dermatomyositis Patients: Experience of a Single‐Center Longitudinal Cohort in North America

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation–associated protein 5 (MDA5) antibody–associated dermatomyositis (DM). Methods Thirty patients with MDA5 antibody–associated DM were identified in a single‐center longitudinal cohort of 352
Jenice X. Cheah   +8 more
wiley   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Oral Medicine in Latin America and the Caribbean: A comprehensive survey of recognition, training, and practice. [PDF]

open access: yesMed Oral Patol Oral Cir Bucal
Saldivia-Siracusa C   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy